# LEVANT Japan Clinical Trial

> **NCT01816412** · PHASE2 · COMPLETED · sponsor: **C. R. Bard** · enrollment: 110 (actual)

## Conditions studied

- Femoral Arterial Stenosis
- Stenosis of Popliteal Arteries
- Femoral Artery Occlusion
- Occlusion of Popliteal Arteries

## Interventions

- **DEVICE:** MD02-LDCB Paclitaxel coated balloon catheter
- **PROCEDURE:** Standard Uncoated Balloon Angioplasty Catheter

## Key facts

- **NCT ID:** NCT01816412
- **Lead sponsor:** C. R. Bard
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-12
- **Final completion:** 2016-06
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2016-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01816412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01816412, "LEVANT Japan Clinical Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01816412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*